← Back to headlines
Ironwood Pharmaceuticals Strengthens Growth Outlook with Expanded Linzess Pediatric Approval
Ironwood Pharmaceuticals, Inc. (IRWD) is reportedly strengthening its growth outlook following an expanded pediatric approval for its drug Linzess.
2 Jun, 13:58 — 2 Jun, 13:58
Sources
Showing 1 of 1 sources
